非透析慢性肾脏病患者饮食管理方案的构建及应用

注册号:

Registration number:

ChiCTR2500112752 

最近更新日期:

Date of Last Refreshed on:

2025-11-19 10:06:14 

注册时间:

Date of Registration:

2025-11-19 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

非透析慢性肾脏病患者饮食管理方案的构建及应用

Public title:

Construction and Application of Dietary Management Plan for Non-dialysis Chronic Kidney Disease Patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

非透析慢性肾脏病患者饮食管理方案的构建及应用

Scientific title:

Construction and Application of Dietary Management Plan for Non-dialysis Chronic Kidney Disease Patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

武慧源 

研究负责人:

张颖惠 

Applicant:

Wu Huiyuan 

Study leader:

Zhang Yinghui 

申请注册联系人电话:

Applicant telephone:

+86 175 3516 5378

研究负责人电话:

Study leader's
telephone:

+86 175 3516 5378

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1989857353@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1989857353@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

山西省太原市迎泽区新建南路56号

研究负责人通讯地址:

山西省太原市杏花岭区五一路382号

Applicant address:

No. 56, Xiangjian South Road, Yingze District, Taiyuan City, Shanxi Province

Study leader's address:

No. 382, Wuyi Road, Xinghualing District, Taiyuan City, Shanxi Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

山西医科大学

Applicant's institution:

Shanxi Medical University

研究负责人所在单位:

山西医科大学第二医院

Affiliation of the Leader:

The Second Hospital of Shanxi Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2025]YX第237号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

山西医科大学第二医院伦理委员会

Name of the ethic committee:

The Ethics Committee of the Second Hospital of Shanxi Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2025-06-28 00:00:00

伦理委员会联系人:

牛金亮

Contact Name of the ethic committee:

Niu Jinliang

伦理委员会联系地址:

山西省太原市杏花岭区五一路382号

Contact Address of the ethic committee:

No. 382, Wuyi Road, Xinghualing District, Taiyuan City, Shanxi Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 137 5312 3937

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

山西医科大学第二医院

Primary sponsor:

The Second Hospital of Shanxi Medical University

研究实施负责(组长)单位地址:

山西省太原市杏花岭区五一路382号

Primary sponsor's address:

No. 382, Wuyi Road, Xinghualing District, Taiyuan City, Shanxi Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山西

市(区县):

Country:

China

Province:

Shanxi

City:

单位(医院):

山西医科大学第二医院

具体地址:

山西省太原市杏花岭区五一路382号

Institution
hospital:

The Second Hospital of Shanxi Medical University

Address:

No. 382, Wuyi Road, Xinghualing District, Taiyuan City, Shanxi Province

经费或物资来源:

研究生课题

Source(s) of funding:

postgraduate research

研究疾病:

慢性肾脏病  

Target disease:

chronic renal failure

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1.了解当前非透析CKD患者饮食管理方案,探究患者当前的饮食体验,归纳其饮食行为的促进与障碍因素,并明确患者的偏好及需求; 2.基于ITHBC理论,构建适合于非透析CKD患者的饮食管理方案,为临床进行非透析CKD患者的营养管理提供参考; 3.探索基于ITHBC的营养管理方案对于非透析CKD患者自我管理、饮食依从性、营养状态、生活质量、肾功能的具体影响。  

Objectives of Study:

1. Understand the current dietary management plans for non-dialysis CKD patients, explore patients' current dietary experiences, summarize the facilitators and barriers to their dietary behaviors, and identify patients' preferences and needs; 2. Based on the ITHBC theory, develop a dietary management plan suitable for non-dialysis CKD patients, providing a reference for clinical nutrition management of these patients; 3. Explore the specific effects of an ITHBC-based nutritional management plan on non-dialysis CKD patients' self-management, dietary adherence, nutritional status, quality of life, and kidney function.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.已进行透析或肾移植的患者; 2.生活不能自理的患者; 3.有认知功能障碍或精神疾患的患者; 4.合并其他严重疾病的患者; 5.存在严重并发症的患者。

Exclusion criteria:

1. Patients who have undergone dialysis or kidney transplantation; 2. Patients who are unable to care for themselves; 3. Patients with cognitive impairment or mental disorders; 4. Patients with other severe diseases; 5. Patients with serious complications.

研究实施时间:

Study execute time:

From 2025-11-20 00:00:00 To 2026-02-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-11-20 00:00:00 To 2025-11-30 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

50

Group:

Intervention group

Sample size:

干预措施:

在常规营养管理的基础上实施基于ITHBC理论的营养管理方案

干预措施代码:

Intervention:

Implement a nutrition management program based on ITHBC theory on the basis of conventional nutrition management

Intervention code:

组别:

对照组

样本量:

50

Group:

Control group

Sample size:

干预措施:

实施常规治疗和营养管理

干预措施代码:

Intervention:

Implement routine treatment and nutritional management

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山西 

市(区县):

 

Country:

China

Province:

Shanxi

City:

单位(医院):

山西医科大学第二医院 

单位级别:

三甲 

Institution
hospital:

The Second Hospital of Shanxi Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

肾脏病饮食依从态度和行为量表

指标类型:

主要指标

Outcome:

Kidney Disease Diet Adherence Attitude and Behavior Scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

7分全面主观评估

指标类型:

次要指标

Outcome:

7-point SGA

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血清白蛋白(ALB)、前白蛋白(PA)、血红蛋白(Hb)、胆固醇、甘油三酯测定

指标类型:

次要指标

Outcome:

Serum albumin (ALB), prealbumin (PA), hemoglobin (Hb), cholesterol, triglycerides determination

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

CKD生活质量量表

指标类型:

次要指标

Outcome:

CKD Quality of Life Scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

None

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-11-19 10:06:04